Laura K Bachrach
Affiliation: Stanford University
- Osteoporosis and measurement of bone mass in children and adolescentsLaura K Bachrach
Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
Endocrinol Metab Clin North Am 34:521-35, vii. 2005..The goals are to demystify the densitometry report and to clarify the role of bone density tests in assessing and managing skeletal health in children...
- Measuring bone mass in children: can we really do it?Laura K Bachrach
Stanford University School of Medicine, CA 94305, USA
Horm Res 65:11-6. 2006..Developing a clearer understanding of how measures of bone mass and strength correlate with bone fracture in children will help target preventive strategies for those in greatest need...
- Clinical review 1: Bisphosphonate use in childhood osteoporosisLaura K Bachrach
Stanford University School of Medicine, Stanford, California 94305, USA
J Clin Endocrinol Metab 94:400-9. 2009..This review examines available research on the efficacy and safety of bisphosphonate therapy for pediatric osteoporosis...
- Taking steps towards reducing osteoporosis in Duchenne muscular dystrophyLaura K Bachrach
Division of Endocrinology, Department of Pediatrics, Stanford University Medical Center, Room S302, 300 Pasteur Drive, Stanford, CA 94305-5208, USA
Neuromuscul Disord 15:86-7. 2005
- Assessing bone health in children: who to test and what does it mean?Laura K Bachrach
Stanford Medical Center, Stanford, CA 94305 5208, USA
Pediatr Endocrinol Rev 2:332-6. 2005..Further research is needed to refine the indications for bone density testing in children and to aid in the interpreting the results...
- The effect of oral contraceptives on bone mass and stress fractures in female runnersKristin L Cobb
Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA 94305, and Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY, USA
Med Sci Sports Exerc 39:1464-73. 2007..To determine the effect of oral contraceptives (OC) on bone mass and stress fracture incidence in young female distance runners...
- Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official PositionsCatherine M Gordon
Division of Endocrinology, Children s Hospital Boston, Boston, MA 02115, USA
J Clin Densitom 11:43-58. 2008..The rationale and evidence for development of the Official Positions are provided. Given the sparse data currently available in many of these areas, it is likely that these positions will change over time as new data become available...
- Low-dose intravenous pamidronate reduces fractures in childhood osteoporosisLaura M Gandrud
Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305 5208, USA
J Pediatr Endocrinol Metab 16:887-92. 2003..Clinically significant hypocalcemia did not occur. Low-dose pamidronate appears promising in the treatment of childhood osteoporosis...
- Risk factors for stress fracture among young female cross-country runnersJennifer L Kelsey
Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, and Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY, USA
Med Sci Sports Exerc 39:1457-63. 2007..To identify risk factors for stress fracture among young female distance runners...
- Disordered eating, menstrual irregularity, and bone mineral density in female runnersKristin L Cobb
Division of Epidemiology, Department of Health Research and Policy, Stanford University, Stanford, CA 94305, USA
Med Sci Sports Exerc 35:711-9. 2003..To examine the relationships between disordered eating, menstrual irregularity, and low bone mineral density (BMD) in young female runners...
- Bone mineral density in pediatric transplant recipientsMark W Daniels
Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA
Transplantation 76:673-8. 2003..Low bone density and the occurrence of vertebral fractures indicate that cardiac, renal, and bone marrow transplantation in children is associated with reduced bone health...
- Bone health in children and adolescents: a symposium at the annual meeting of the Pediatric Academic Societies/Lawson Wilkins Pediatric Endocrine Society, May 2003Catherine M Gordon
Division of Endocrinology, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA
Curr Probl Pediatr Adolesc Health Care 34:226-42. 2004
- Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious pubertyAngela Badaru
Division of Pediatric Endocrinology and Diabetes, Stanford University, Stanford, California 94305, USA
J Clin Endocrinol Metab 91:1862-7. 2006..Whether various DL doses lead to long-term therapeutic differences remains to be determined...
- Correlates of low bone mass in children with generalized forms of epidermolysis bullosaAnna L Bruckner
Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94305 5168, USA
J Am Acad Dermatol 65:1001-9. 2011..Epidermolysis bullosa (EB) is a family of rare, heterogeneous, genetic disorders characterized by fragility of the skin and mucous membranes. Reduced bone mass and fractures have been recognized as complications of generalized forms of EB...
- Comparison of calcaneus ultrasound and dual X-ray absorptiometry in children at risk of osteopeniaKrista T Fielding
Stanford University School of Medicine, Stanford, CA, USA
J Clin Densitom 6:7-15. 2003..84, and 0.84, respectively. While CUS correlates only modestly with DXA, ROC curve areas indicate that CUS detects low bone mineral in children with fragility fractures as well as DXA and may be a viable initial screen for osteopenia...
- When to use bisphosphonatesLaura K Bachrach
J Pediatr 144:285; author reply 285-6. 2004
- Diet in midpuberty and sedentary activity in prepuberty predict peak bone massMay Choo Wang
Department of Nutritional Sciences and the School of Public Health, University of California, Berkeley, 94720 7360, USA
Am J Clin Nutr 77:495-503. 2003..An average daily calcium intake of 1300 mg is recommended for North American adolescents aged 9-18 y. However, questions remain about these recommendations...
- Osteoporosis in children: still a diagnostic challengeLaura K Bachrach
J Clin Endocrinol Metab 92:2030-2. 2007
- Effects of pharmacologic agents on bone in childhood: an editorial overviewGordon L Klein
Pediatrics 119:S125-30. 2007
- Bare-bones fact--children are not small adultsLaura K Bachrach
N Engl J Med 351:924-6. 2004
- Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera) effects on bone health in adolescents: study design, population characteristics and baseline bone mineral densityChristine C Johnson
Henry Ford Hospital, Detroit, MI 48202 3450, USA
Contraception 77:239-48. 2008..nonuse of the injectable (intramuscular) contraceptive depot medroxyprogesterone acetate (DMPA-IM) and its effect on bone mass in adolescent women...
- Pitfalls in the hunt for osteoporosisLaura K Bachrach
Am J Med 115:322-3. 2003
- Contraceptive use in teens: a threat to bone health?Melanie A Gold
J Adolesc Health 35:427-9. 2004
- Official positions of the international society for clinical densitometryE Michael Lewiecki
New Mexico Clinical Research and Osteoporosis Center, Albuquerque, New Mexico 87106, USA
J Clin Endocrinol Metab 89:3651-5. 2004..Recommendations that are accepted become the Official Positions of the ISCD. This Special Report summarizes the methodology of the ISCD Position Development Conferences and presents selected Official Positions of general interest...